Will Morton is an Associate Editor at AuntMinnie.com. He focuses on a variety of themes including medicine and healthcare, diagnostics, and the integration of AI and machine learning within the healthcare system. Will's work has been featured in prominent publications such as NewsBreak, Cook Medical Australia, and LabPulse.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Will Morton's coverage heavily focuses on scientific topics, particularly in the field of radiology and PET/CT scans. Given this, he would likely respond well to pitches from experts who can provide data-driven insights into these areas.
As a journalist citing data frequently, Will would likely appreciate outreach from professionals with access to new research findings or statistical analysis related to the specific scientific themes and topics he covers. Additionally, given his focus on racial and gender biases in AI, experts who can offer unique perspectives or studies related to bias mitigation in AI could also be of interest.
While there is no explicit geographic focus mentioned for Will's coverage, it seems that his reporting spans international developments within the scientific community. Therefore, sources with global perspectives on relevant scientific advancements may find success when reaching out to him.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Dec 11, 2024 Shutting down angiography imaging systems after 15 minutes of idle time has the potential to save nearly half of the system's
A new PET radiotracer has the potential for visualizing responses in liver cancer patients undergoing immunotherapy, according to a study published December 12 in the Journal of Nuclear Medicine.
Kyphoplasty and vertebroplasty – two minimally invasive image-guided procedures to treat osteoporotic vertebral fractures – appear to be effective for decreasing long-term use of pain medication, according to a December 5 presentation at RSNA.
F-18 fluorothymidine PET can identify early acute gastrointestinal graft versus host disease after patients undergo bone marrow transplants.
African American men with metastatic castrate-resistant prostate cancer (mCRPC) appear to respond more favorably than white men to treatment with radium-223 (Ra-223) dichloride, according to a study presented at RSNA.
Kidney-absorbed doses of lutetium-177 (Lu-177)-based treatments for prostate cancer and neuroendocrine tumors appear to be below toxicity thresholds.
Interventional radiologists who excel in communication, positive outcomes, and cultural competence receive high patient ratings, according to a study presented at the recent RSNA meeting.
Rates of PET prostate cancer imaging increased rapidly after its approval by the U.S. Food and Drug Administration (FDA).
Negative prostate-specific antigen (PSMA) PET scans can be used to avoid unnecessary pelvic lymph node dissection in certain prostate cancer patients undergoing radical prostatectomies.
New appropriate use criteria for amyloid and tau PET imaging of amyloid and tau pathology has been released.
(833) 317-6278 
